Tendon, ligament, and cartilage injuries resulting from aging or athletic activities are prevalent health issues globally. Yet they are often underestimated as contributors to long-term disability, reduced quality of life, and increased healthcare expenses. Although both surgical and non-surgical treatments are available, they come with extended recovery periods, fail to fully restore the natural biological and mechanical functions of the tissues, and may lead to complications due to foreign materials. This result in complex requirements for the 3D bioprinting ink processed during bioprinting, since it must be biocompatible on the one hand, and on the other hand, it should have suitable properties (viscosity, surface tension) for the printing process and determine the material properties of the printed tissue equivalent. To tackle these challenges the effective combination of biomaterials, cells, and 3D bioprinting techniques offers a promising solution to overcome the limitations observed in clinical trials when using simple hydrogen scaffolds. The approach aims to replicate the native extracellular environment of orthopaedic soft tissues, thus providing patients with a long-term less invasive and more efficient method to treat these injuries. In order to replicate the biochemical and mechanical characteristics of healthy cartilage and tendon structures, we developed 3D bioprintable scaffolds using methacrylated biomaterials. These modified biomaterials offer the advantage of flexibility in adjusting the stiffness of the hydrogel scaffolds through the process of photopolymerization. Additionally, they exhibit excellent printability and enable the fabrication of patient-specific, temporally, and spatially controlled multi-layered hydrogel scaffolds.